AbbVie to Showcase Breadth of Neuroscience Portfolio and Pip

-- AbbVie to present 30 abstracts demonstrating its leadership in neuroscience, including continued migraine treatment research across the spectru...

Related Keywords

United States , Germany , Cambridge , Cambridgeshire , United Kingdom , Ludwigshafen , Rheinland Pfalz , Massachusetts , American , Lou Gehrig , Coadministered Atogepant , Foslevodopa Foscarbidopa , Instagram , Linkedin , Foundational Neuroscience Center , Twitter , Drug Administration , Youtube , Neuroscience Development , Facebook , American Academy Of Neurology , Annual Meeting , Michael Gold , Therapeutic Area Head , Cortical Spreading Depression , Monthly Headache Days , Migraine Related Quality , Migraine Days , Acute Medication Use Days , Migraine Specific Quality , Post Hoc Analysis , Migraine Attacks , Healthcare Resource Utilization , Diagnosed Drug Induced Headache , Potential Acute Medication Overuse , Person Analysis , Ubrogepant Treatment , Mild Versus Moderate Severe Headache Pain , Term Safety Extension Trial , Pharmacokinetic Interaction , Long Term Safety , Oral Atogepant , Once Daily , Preventive Treatment , Multicenter Extension , Cardiovascular Disease Risk Factors , Once Daily Shows Efficacy , Week Open Label Extension Trial , Body Weight , Once Daily Atogepant , World Persistence , Costs Among Patients , Chronic Migraine Treated , Retrospective Claims Analysis Study , Real World Use , Acute Treatment , Anti Calcitonin Gene , Related Peptide Monoclonal Antibody Preventive , Person Consistency , Acute Treatment Success , Long Term Safety Study , World Effectiveness , Migraine When Used , Ubrogepant Among Participants , Prior Treatment Failure , Subgroup Analysis , Novel Approach , Defining Success , Demonstrating Therapeutic Benefit , Hour Post Dose , Day Subcutaneous Infusion , Advanced Parkinson , Disease During , Month Interim Results , Long Term Effectiveness , Levodopa Carbidopa Intestinal Gel , Non Motor Symptom Benefits , Disease Treated , Baseline Hoehn , Yahr Stage , Final Analysis , Multinational Observational Study , Antibody Conversion , Global Studies Across Multiple Indications , Resource Utilization , Stroke Related Spasticity Before , After Treatment , Virtual Reality Platform , Facilitate Training , Lower Limb Spasticity , Disease Severity , Presentation Subtype , Onabotulinumtoxina Utilization , Cervical Dystonia , Medication Guide , Product Information , Prescribing Information , Neuroscience Discovery , Allergan Aesthetics ,